Phase II Trial of Topotecan, Carboplatin, and Paclitaxel as Front-Line Therapy in Suboptimal Advanced Epithelial Ovarian Cancer

By Bolis G.   Scarfone G.   Villa A.   Parazzini F.  

Gynecologic Oncology, Vol. 81, Iss. 2, 2001-05 ,pp. : 331-333

Elsevier

Access to resources Recommend Favorite

Phase II Trial of Vinorelbine in Recurrent and Progressive Epithelial Ovarian Cancer

By Burger R.A.   DiSaia P.J.   Roberts J.A.   O'Rourke M.   Gershenson D.M.   Homesley H.D.   Lichtman S.M.   Barnes W.   Moore D.H.   Monk B.J.  

Gynecologic Oncology, Vol. 72, Iss. 2, 1999-02 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite

Phase II trial of carboxyamidotriazole in patients with relapsed epithelial ovarian cancer

By Hensley Martee  

The Women's Oncology Review, Vol. 4, Iss. 1, 2004-01 ,pp. : 51-52

Informa Healthcare

Access to resources Recommend Favorite

A Phase II Trial of Daily Perillyl Alcohol in Patients with Advanced Ovarian Cancer: Eastern Cooperative Oncology Group Study E2E96

By Bailey H.H.   Levy D.   Harris L.S.   Schink J.C.   Foss F.   Beatty P.   Wadler S.  

Gynecologic Oncology, Vol. 85, Iss. 3, 2002-06 ,pp. : 464-468

Academic Press

Access to resources Recommend Favorite

Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer Group

By Aapro M.S.   van Wijk F.H.   van der Burg M.E.L.   ten Bokkel Huinink W.   Vergote I.   Guastalla J.P.   Rosso R.   Kobierska A.   Beex L.V.A.   Namer M.   Splinter T.E.W.   Vermorken J.B.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1141-1143

Elsevier

Access to resources Recommend Favorite